Amass

The Life Science Data API

Employees
1–10
Business Model
B2B
Website
amass.tech
Last Round
SeedAug 2025
Rounds
1

About

Amass turns fragmented scientific knowledge into a shared intelligence layer for life science teams. The platform retrieves, verifies, structures, and reuses evidence from literature, patents, clinical trials, regulatory documents, drugs, genes, and internal sources, with every answer traceable to the underlying source. Researchers, investors, developers, and strategy teams use Amass for due diligence, competitive intelligence, literature review, pipeline monitoring, and scientific strategy. Amass Technologies ApS offers the engine via a workspace app, API, and MCP, indexing 500M+ life science documents across specialized data layers.

Summary

Amass is an Artificial Intelligence company. Its most recent funding was a Seed round in Aug 2025. Investors include Giant Ventures and Export & Investment Fund of Denmark.

Tech & App Stack

7 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

SeedAug 2025

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Amass on Indexed.vc
<a href="https://indexed.vc/companies/amass"><img src="https://indexed.vc/api/badge/company/amass" alt="Amass on Indexed.vc" width="260" height="76" /></a>